Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant V260 and IPV in Chinese Infants
NCT04481191Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2020
- Primary completion
- May 2021
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of rotavirus vaccine, live, oral, pentavalent in rotavirus gastroenteritis, sponsored by Merck & Co.. Started Aug 2020; status: completed.
02
Drugs
rotavirus vaccine, live, oral, pentavalent
03
Conditions
rotavirus gastroenteritis
Beyond the preview
Go deeper on NCT04481191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04481191.